Effects of Intra-articular Hypertonic Dextrose and Hyaluronic Acid on Primary Knee Osteoarthritis.

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

May 4, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2026

Conditions
Mild to Moderate Knee OA
Interventions
DRUG

prolotherapy solution of 20% dextrose

This intervention is open label. Both participants and investigator will know about the intervention. Participants are allocated according to simple randomization by lottery. Two groups with each contain 28 participants. One group will be given a mixture of intra-articular injection of 5.6 ml 25% dextrose and 1.4 ml 2% lignocaine to achieve a final concentration 20% dextrose with 0.4% lignocaine in the involved knee joint. Another group will be given 1.4 ml 2% lignocaine followed by 2 ml high molecular weight hyaluronic acid intra-articularly in the involved joint.

DRUG

Hyaluronic Acid (HA)

This intervention is open label. Both participants and investigator will know about the intervention. Participants are allocated according to simple randomization by lottery. Two groups with each contain 28 participants. One group will be given a mixture of intra-articular injection of 5.6 ml 25% dextrose and 1.4 ml 2% lignocaine to achieve a final concentration 20% dextrose with 0.4% lignocaine in the involved knee joint. Another group will be given 1.4 ml 2% lignocaine followed by 2 ml high molecular weight hyaluronic acid intra-articularly in the involved joint.

Trial Locations (1)

1000

Bangladesh Medical University (formerly known as Bangabandhu Sheikh Mujib Medical University), Dhaka

All Listed Sponsors
lead

Bangladesh Medical University

OTHER

NCT07102225 - Effects of Intra-articular Hypertonic Dextrose and Hyaluronic Acid on Primary Knee Osteoarthritis. | Biotech Hunter | Biotech Hunter